Development of potential anticancer agents that target the telomere sequence

被引:8
|
作者
Park, Myunji [1 ]
Bruice, Thomas C. [1 ]
机构
[1] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA
关键词
Telomere; Telomerase; Cancer; DEOXYNUCLEIC GUANIDINE DNG; SOLID-PHASE SYNTHESIS; DEOXYRIBONUCLEIC GUANIDINE; BINDING; LINKAGES; FIDELITY; RNA; HOMOPOLYNUCLEOTIDES; OLIGONUCLEOTIDES; CHROMOSOMES;
D O I
10.1016/j.bmcl.2010.04.089
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The immortality of cancer cells is due to the relatively high concentration of telomerase enzyme that maintains the telomere sequence during cell division. Human telomeric DNA consists of repeats of the sequence d(5'-TTAGGG-3'). Deoxyribonucleic guanidine ( DNG) is a DNA analog in which positively charged guanidine [-NH-C(=NH2+)-NH-] replaces the negatively charged phosphodiester of DNA. The synthesized DNG hexamer AgAgTgCgCpC and dodecamer AgAgTgCgCgCAgAgTgCgCpC are complementary to the non-coding telomere sequence d(5'-TTAGGG-3'). We have found that binding of the complementary DNG hexamer to the telomere is favored over that of DNA telomere by 10(2.5)-fold and binding the dodecamer with 2-mismatched DNA is favored by 10(5)-fold. We have shown that DNG binding to RNA is favored over binding to DNA. A complementary complex of DNG with RNA at the active site of telomerase enzyme would be very stable. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3982 / 3986
页数:5
相关论文
共 50 条
  • [1] Development of chalcones as potential anticancer agents
    Ducki, Sylvie
    Lawrence, Nicholas J.
    Snyder, James P.
    Greedy, Benjamin
    Chabert, Jeremie Fournier dit
    Mackenzie, Grant
    Nettles, James
    Cook, Darren
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [2] Pyridazinones: A versatile scaffold in the development of potential target-based novel anticancer agents
    Singh, Jyoti
    Kumar, Vipan
    Silakari, Pragati
    Kumar, Sandeep
    [J]. JOURNAL OF HETEROCYCLIC CHEMISTRY, 2023, 60 (06) : 929 - 949
  • [3] Cdc25 as a Potential Target of Anticancer Agents
    Jens W. Eckstein
    [J]. Investigational New Drugs, 2000, 18 : 149 - 156
  • [4] Cdc25 as a potential target of anticancer agents
    Eckstein, JW
    [J]. INVESTIGATIONAL NEW DRUGS, 2000, 18 (02) : 149 - 156
  • [5] Therapeutic Potential of Genistein and its Derivatives as a Target for Anticancer Agents
    Gupta, Nidhi
    Gupta, Sumeet
    Kumar, Manish
    Guarve, Kumar
    Dhanawat, Meenakshi
    Sharma, Vishal
    [J]. CHEMISTRYSELECT, 2023, 8 (21):
  • [6] Telomere maintenance as a target for anticancer drug discovery
    Neidle, S
    Parkinson, G
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (05) : 383 - 393
  • [7] Telomere maintenance as a target for anticancer drug discovery
    Stephen Neidle
    Gary Parkinson
    [J]. Nature Reviews Drug Discovery, 2002, 1 : 383 - 393
  • [8] Recent development of imidazole derivatives as potential anticancer agents
    Kumar, Naresh
    Goel, Nidhi
    [J]. PHYSICAL SCIENCES REVIEWS, 2022, : 2903 - 2941
  • [9] DNA repair, a potential target for anticancer drug development
    Pourquier, Philippe
    [J]. BULLETIN DU CANCER, 2006, 93 : 124 - 144
  • [10] Recent Developments of Target Based Coumarin Derivatives as Potential Anticancer Agents
    Goud, Nerella Sridhar
    Kumar, Pardeep
    Bharath, Rose Dawn
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2020, 20 (17) : 1754 - 1766